dc.contributor.author | March López, Pablo | |
dc.contributor.author | Arancibia Freixa, Inés | |
dc.contributor.author | Martinez Gil, Mireia | |
dc.contributor.author | Araujo Espinoza, Gastón | |
dc.contributor.author | Ortega Polonio, Lidia | |
dc.contributor.author | Paredes, Elisabeth Cecilia | |
dc.contributor.author | Carrasco Sanchez, Montserrat | |
dc.contributor.author | Sangrador, Cristina | |
dc.contributor.author | Pardo, Júlia | |
dc.contributor.author | Nicolás Picó, Jordi | |
dc.contributor.author | Calbo Sebastián, Esther | |
dc.date.accessioned | 2021-11-15T14:58:43Z | |
dc.date.available | 2021-11-15T14:58:43Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | March-López, Pablo; Arancibia Freixa, Inés; Martinez Gil, Mireia [et al.]. Applicability of quality indicators for appropriate antibiotic use in outpatient parenteral antimicrobial therapy (OPAT): a point prevalence survey. Frontiers in Pharmacology, 2021, 12, 713882. Disponible en: <https://www.frontiersin.org/articles/10.3389/fphar.2021.713882/full>. Fecha de acceso: 15 nov. 2021. DOI: 10.3389/fphar.2021.713882 | ca |
dc.identifier.issn | 1663-9812 | ca |
dc.identifier.uri | http://hdl.handle.net/20.500.12328/2944 | |
dc.description.abstract | The ability to measure the quality of antibiotic prescription is a critical element in any antimicrobial stewardship programme. The aim of this study was to evaluate the clinimetric properties of 33 quality indicators (QIs) developed to assess Outpatient Parenteral Antimicrobial Therapy (OPAT) and to identify potential room for improvement in a hospital-at-home (HaH) unit. Study performed in a healthcare district in Barcelona, Spain with 260,657 inhabitants, nine primary healthcare centres, a 400-bed acute care teaching hospital, and an HaH unit. We studied 33 QIs on appropriate antibiotic use and classified them as qualitative or quantitative. Quantitative QIs were further categorized as measurable or non-measurable depending on the availability of data in the patients’ medical records. Data from 202 OPAT episodes in 192 patients were assessed. Adherence was found for 22 of the 24 qualitative QIs analyzed; the other two showed room for improvement. Four of the nine quantitative indicators were non-measurable. High adherence rates were achieved for QI-17 “The OPAT plan should be documented” (84.65%), QI-26 “The OPAT treatment plan should include choice, dose, frequency, duration and follow-up plan” (79.70%), and QI-33 “The team should document clinical response” (94.55%). Adverse events were documented in just 1.98% of cases (QI-32) and 92.57% patients were classified as alive on discharge (QI-24). The QIs evaluated were applicable to clinical practice and proved useful for identifying areas with room for improvement in our setting and for guiding the design of future interventions with specific objectives. | en |
dc.format.extent | 7 | ca |
dc.language.iso | eng | ca |
dc.publisher | Frontiers Media | ca |
dc.relation.ispartof | Frontiers in Pharmacology | ca |
dc.relation.ispartofseries | 12; | |
dc.rights | © 2021 March-López, Freixa, Gil, Espinoza, Polonio, Paredes, Sanchez, Sangrador, Pardo, Nicolás and Calbo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. | en |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.subject.other | Hospital a casa | ca |
dc.subject.other | Resistència antimicrobiana | ca |
dc.subject.other | Antibiòtics | ca |
dc.subject.other | Indicador de qualitat | ca |
dc.subject.other | Teràpia antibiòtica parenteral ambulatòria | ca |
dc.subject.other | Hospital en casa | es |
dc.subject.other | Resistencia antimicrobiana | es |
dc.subject.other | Antibióticos | es |
dc.subject.other | Indicador de calidad | es |
dc.subject.other | Terapia antibiótica parenteral ambulatoria | es |
dc.subject.other | Hospital at home | en |
dc.subject.other | Antimicrobial resistance | en |
dc.subject.other | Antibiotics | en |
dc.subject.other | Quality indicator | en |
dc.subject.other | Outpatient parenteral antibiotic therapy | en |
dc.title | Applicability of quality indicators for appropriate antibiotic use in outpatient parenteral antimicrobial therapy (OPAT): a point prevalence survey | en |
dc.type | info:eu-repo/semantics/article | ca |
dc.description.version | info:eu-repo/semantics/publishedVersion | ca |
dc.rights.accessLevel | info:eu-repo/semantics/openAccess | |
dc.embargo.terms | cap | ca |
dc.subject.udc | 61 | ca |
dc.subject.udc | 616.9 | ca |
dc.identifier.doi | https://dx.doi.org/10.3389/fphar.2021.713882 | ca |